![](https://i0.wp.com/adlilab.org/wp-content/uploads/2022/12/header-research-copy-1.jpg?resize=1529%2C1275&ssl=1)
Our Research
Main Goal
Identify and target key genomic and epigenomic drivers in chronic human diseases.
Tools and technologies we utilize to achieve our goal
![](https://i0.wp.com/adlilab.org/wp-content/themes/chuo/assets/images/elements-background-secondary-30.png?ssl=1)
Genome Mapping
![](https://i0.wp.com/adlilab.org/wp-content/uploads/2022/12/aa1-1.png?resize=487%2C1024&ssl=1)
Genome & Epigenome editing
![](https://i0.wp.com/adlilab.org/wp-content/uploads/2022/12/aa2.png?resize=487%2C1024&ssl=1)
Computational Data Analysis
![](https://i0.wp.com/adlilab.org/wp-content/uploads/2022/12/aa3-6.png?resize=486%2C1024&ssl=1)
Our main research areas:
We apply the above tool and technologies in various malignant settings, such as ovarian and pancreatic cancers, and several reproductive diseases settings, such as fibroids.
Characterizing human
genes
![](https://i0.wp.com/adlilab.org/wp-content/uploads/2022/12/rresearch-2ndboxes-1st.png?resize=517%2C1024&ssl=1)
Understanding and targeting
chemoresistance in cancer
![](https://i0.wp.com/adlilab.org/wp-content/uploads/2022/12/rresearch-2ndboxes-2nd.png?resize=517%2C1024&ssl=1)
Modeling disease-associated genetic
abnormalities
![](https://i0.wp.com/adlilab.org/wp-content/uploads/2022/12/rresearch-2ndboxes-3rd.png?resize=516%2C1024&ssl=1)
High throughput CRISPR screening for combinatorial drug targets
![](https://i0.wp.com/adlilab.org/wp-content/uploads/2022/12/rresearch-2ndboxes-4th.png?resize=517%2C1024&ssl=1)